Gene · 2921
NIH grants2,607
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,741 to 1,760 of 2,607
Download this page as JSON| Grant | Title | CXCL3 papers | Newest fiscal year |
|---|---|---|---|
| R01NS078026 | PGE2 EP1 and EP3 receptors as therapeutic targets in intracerebral hemorrhage | 1 | 2016 |
| R01NS078501 | Role of C-type Lectin Receptors in Myeloid Plasticity in Neurocysticercosis | 1 | 2016 |
| R01NS081149 | Regulatory Control of Glutamate - Induced Superoxide Production | 1 | 2016 |
| R03AI112808 | Impact of Maternal Obesity on the Neonatal Immune System | 1 | 2016 |
| R03DK107960 | Harnessing human gastric organoids to investigate the role of CD103 in gastric dendritic cell – epithelial cell crosstalk | 1 | 2016 |
| R03MH105655 | Social Sensitivity and Depression in Peer-Victimized Girls: Insights from Neuroscience | 1 | 2016 |
| R13ES027302 | 2016 SETAC Asia/Pacific Conference | 1 | 2016 |
| R15CA202775 | Targeting IKK and HDAC Mediated IL-8 Expression in Ovarian and Prostate Cancer | 1 | 2016 |
| R21AG050437 | Evaluating GWAS AMD Candidate Loci by Gene Editing in Human iPS Cells | 1 | 2016 |
| R21CA195689 | Stromal Interactions and Leukemic Risk in Myelodysplastic Syndromes | 1 | 2016 |
| R21DE025352 | Role of HPV in oral cavity squamous cell carcinoma | 1 | 2016 |
| R21ES024666 | Ozone, lipid-protein adducts, and biological effects | 1 | 2016 |
| R21EY025061 | Study of the ER-mitochondria interface as a new target in diabetic retinopathy | 1 | 2016 |
| R37DK042394 | Role of the Unfolded Protein Response in Beta Cell | 1 | 2016 |
| R41HL126456 | HLS13-13 Albumin nanoparticle based technology to treat ARDS | 1 | 2016 |
| R44OD012083 | Co-axial Microinjection System for Freezing and Biopsy of Early Embryos | 1 | 2016 |
| R56AI093903 | Role of aryl hydrocarbon receptor in IL-10 producing Tr1 regulatory cells | 1 | 2016 |
| R56HL128285 | Targeted Cell Therapy for Acute Lung Injury | 1 | 2016 |
| RF1AG054014 | Molecular Characterization and Validation of Gender Differences in Alzheimers Disease Pathogenesis | 1 | 2016 |
| SC1GM095426 | Role of CX3CR1 in adaptive immunity during autoimmune encephalomyelitis | 1 | 2016 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/grants?page=88